Literature DB >> 29262361

Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.

Angana Ray1, Navjeet Ahalawat1, Jagannath Mondal2.   

Abstract

Among various isoforms of Apolipoprotein E (ApoE), the E4 isoform (ApoE4) is considered to be the strongest risk factor for Alzheimer's disease, whereas the E3 isoform (ApoE3) is neutral to the disease. Interestingly, the sequence of ApoE4 differs from its wild-type ApoE3 by a single amino acid C112R in the 299-amino-acid-long sequence. Hence, the puzzle remains: how a single-amino-acid difference between the ApoE3 and ApoE4 sequences can give rise to structural dissimilarities between the two isoforms, which can potentially lead to functional differences with significant pathological consequences. The major obstacle in addressing this question has been the lack of a 3D atomistic structure of ApoE4 to date. In this work, we resolve the issue by computationally modeling a plausible atomistic 3D structure of ApoE4. Our microsecond-long atomistic simulations elucidate key structural differences between monomeric ApoE3 and ApoE4, which renders ApoE4 thermodynamically less stable, less structured, and topologically less rigid compared to ApoE3. Consistent with an experimental report of the molten globule state of ApoE4, simulations identify multiple partially folded intermediates for ApoE4, which are implicated in the stronger aggregation propensity of ApoE4.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29262361      PMCID: PMC5770556          DOI: 10.1016/j.bpj.2017.10.006

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  59 in total

1.  CHARMM-GUI: a web-based graphical user interface for CHARMM.

Authors:  Sunhwan Jo; Taehoon Kim; Vidyashankara G Iyer; Wonpil Im
Journal:  J Comput Chem       Date:  2008-08       Impact factor: 3.376

2.  Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.

Authors:  Palaniappan S Chetty; Leland Mayne; Sissel Lund-Katz; S Walter Englander; Michael C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 4.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Authors:  J P Segrest; M K Jones; H De Loof; C G Brouillette; Y V Venkatachalapathi; G M Anantharamaiah
Journal:  J Lipid Res       Date:  1992-02       Impact factor: 5.922

5.  A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.

Authors:  Carl Frieden; Hanliu Wang; Chris M W Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

Review 6.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Authors:  Simon M Laws; Eugene Hone; Sam Gandy; Ralph N Martins
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

7.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

9.  A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity.

Authors:  Arun Sivashanmugam; Jianjun Wang
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

10.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.

Authors:  Jumin Lee; Xi Cheng; Jason M Swails; Min Sun Yeom; Peter K Eastman; Justin A Lemkul; Shuai Wei; Joshua Buckner; Jong Cheol Jeong; Yifei Qi; Sunhwan Jo; Vijay S Pande; David A Case; Charles L Brooks; Alexander D MacKerell; Jeffery B Klauda; Wonpil Im
Journal:  J Chem Theory Comput       Date:  2015-12-03       Impact factor: 6.006

View more
  7 in total

Review 1.  APOE in the normal brain.

Authors:  Sarah A Flowers; G William Rebeck
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

Review 2.  Interpretable artificial intelligence and exascale molecular dynamics simulations to reveal kinetics: Applications to Alzheimer's disease.

Authors:  William Martin; Gloria Sheynkman; Felice C Lightstone; Ruth Nussinov; Feixiong Cheng
Journal:  Curr Opin Struct Biol       Date:  2021-10-07       Impact factor: 6.809

3.  In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (Aβ) Complex at Different pH Conditions.

Authors:  Jorge Alberto Aguilar-Pineda; Silvana G Paco-Coralla; Camilo Febres-Molina; Pamela L Gamero-Begazo; Pallavi Shrivastava; Karin J Vera-López; Gonzalo Davila-Del-Carpio; Patricia López-C; Badhin Gómez; Christian L Lino Cardenas
Journal:  Biomolecules       Date:  2022-03-25

4.  Apolipoprotein E particle size is increased in Alzheimer's disease.

Authors:  Thomas J Nelson; Abhik Sen
Journal:  Alzheimers Dement (Amst)       Date:  2018-11-13

5.  Significant association of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) rs3846662 and sirtuin 1 (SIRT1) rs7895833 and apolipoprotein E (APOE) hypermethylation with mild cognitive impairment (MCI).

Authors:  Ting Zou; Yali Duan; Xiaohui Zhou; Wei Chen; Xiuru Ying; Guili Liu; Yongjie Zhao; Meisheng Zhu; Abuliz Pari; Kader Alimu; Haijun Miao; Keyim Kabinur; Lei Zhang; Qinwen Wang; Shiwei Duan
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Association between APOE polymorphisms and lipid profile in Mexican Amerindian population.

Authors:  José J Martínez-Magaña; Alma D Genis-Mendoza; Carlos A Tovilla-Zarate; Thelma B González-Castro; Isela Esther Juárez-Rojop; Yazmín Hernández-Díaz; Angélica G Martinez-Hernandez; Humberto Garcia-Ortíz; Lorena Orozco; María L López-Narvaez; Humberto Nicolini
Journal:  Mol Genet Genomic Med       Date:  2019-09-26       Impact factor: 2.183

Review 7.  Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.

Authors:  Yun Chen; Michael R Strickland; Andrea Soranno; David M Holtzman
Journal:  Neuron       Date:  2020-11-10       Impact factor: 17.173

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.